Does ALIROCUMAB Cause Injection site bruising? 821 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 821 reports of Injection site bruising have been filed in association with ALIROCUMAB (Praluent). This represents 3.6% of all adverse event reports for ALIROCUMAB.
821
Reports of Injection site bruising with ALIROCUMAB
3.6%
of all ALIROCUMAB reports
2
Deaths
26
Hospitalizations
How Dangerous Is Injection site bruising From ALIROCUMAB?
Of the 821 reports, 2 (0.2%) resulted in death, 26 (3.2%) required hospitalization, and 1 (0.1%) were considered life-threatening.
Is Injection site bruising Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALIROCUMAB. However, 821 reports have been filed with the FAERS database.
What Other Side Effects Does ALIROCUMAB Cause?
Myalgia (1,571)
Product dose omission (1,354)
Injection site pain (1,220)
Muscle spasms (1,113)
Arthralgia (993)
Fatigue (922)
Pain (892)
Pain in extremity (888)
Product dose omission issue (864)
Device issue (785)
What Other Drugs Cause Injection site bruising?
ETANERCEPT (7,734)
ADALIMUMAB (7,249)
EVOLOCUMAB (4,409)
TERIPARATIDE (4,405)
DUPILUMAB (4,332)
TIRZEPATIDE (2,665)
SECUKINUMAB (1,969)
DULAGLUTIDE (1,832)
HUMIRA (1,623)
EXENATIDE (1,299)
Which ALIROCUMAB Alternatives Have Lower Injection site bruising Risk?
ALIROCUMAB vs ALISKIREN
ALIROCUMAB vs ALISKIREN HEMIFUMARATE
ALIROCUMAB vs ALISKIREN\HYDROCHLOROTHIAZIDE
ALIROCUMAB vs ALIZAPRIDE
ALIROCUMAB vs ALLANTOIN